دورية أكاديمية

Use Via Early Access to Ixazomib (UVEA-IXA) Study: Effectiveness and Safety of Ixazomib-based Therapy in Relapsed/Refractory Multiple Myeloma Outside of the Clinical Trial Setting

التفاصيل البيبلوغرافية
العنوان: Use Via Early Access to Ixazomib (UVEA-IXA) Study: Effectiveness and Safety of Ixazomib-based Therapy in Relapsed/Refractory Multiple Myeloma Outside of the Clinical Trial Setting
المؤلفون: Ludwig, Heinz, Ramasamy, Karthik, Mateos, María-Victoria, Kishore, Bhuvan, Gergely, Varga, Ladicka, Miriam, Ori, Alessandra, Simoni, Lucia, Bent-Ennakhil, Nawal, Stull, Dawn Marie, Gavini, François, Terpos, Evangelos, Hájek, Roman
المصدر: In Clinical Lymphoma, Myeloma and Leukemia February 2024 24(2):e40-e49
قاعدة البيانات: ScienceDirect
الوصف
تدمد:21522650
DOI:10.1016/j.clml.2023.10.003